ArticleDrug design, development and therapy2026

Beyond Indication Expansion: Aligning Evidence, Reimbursement, and Access in Multi-Indication Oncology Drugs [Letter].

Ahmad YusroniPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.